YOUR BUSINESS AUTHORITY

Springfield, MO

Home
Digital Edition
Events
Industries
Opinion
Podcasts
Photo Galleries
News Features
Sponsored Content

Log in Subscribe

Gilead to acquire Arcellx

Posted online February 23, 2026 | 8:09 am

Gilead Sciences has agreed to buy cancer therapy company Arcellx.

The deal is valued at up to $7.8 billion.

The companies entered a cell therapy development collaboration in 2022.

Read more from Reuters.

Comments

No comments on this story |

Please log in to add your comment

More from SBJ Daily Update

Community Focus Report released today

Editors' Pick

Open for Business: MD Hyperbaric

A provider of hyperbaric oxygen therapy opened its first Missouri location on Aug. 12 at 1316 E. Republic Road.

Most Read

Banker pleads guilty to fraud scheme

Wendy's franchisee files for bankruptcy

The Digital Edition from SBJ

SBJ reveals 2027 Coolest Things Made in Missouri honorees

Curb Appeal: 42 listings make the cut in September

Longtime employee sues Ozarks Tech, alleges retaliation

Developer pulls rezoning request for 2900 S. National

SBJ.net Poll

Springfield's jobless rate ticked down from July to August, according to the latest federal data. Is your firm expanding its workforce?

*

Update cookies preferences